Recently, a large number of studies have reported that RIPK4 expressions were distinctly dysregulated in many types of tumors, such as nasopharyngeal carcinoma, osteosarcoma, and bladder urothelial carcinoma cell [11–13]. The gene discussed is RIPK4; the disease is nasopharyngeal carcinoma.